These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 335787)

  • 41. A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior.
    Chan HY; Ree SC; Su LW; Chen JJ; Chou SY; Chen CK; Chen YS
    J Clin Psychopharmacol; 2014 Jun; 34(3):355-8. PubMed ID: 24743717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.
    Carlyle W; Ancill RJ; Sheldon L
    Int Clin Psychopharmacol; 1993; 8(2):103-8. PubMed ID: 8345158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.
    Dorevitch A; Katz N; Zemishlany Z; Aizenberg D; Weizman A
    Am J Psychiatry; 1999 Jan; 156(1):142-4. PubMed ID: 9892313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
    San L; Estrada G; Oudovenko N; Montañés F; Dobrovolskaya N; Bukhanovskaya O; Popov M; Vieta E
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):710-718. PubMed ID: 29724638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Very high dose loxapine in refractory schizophrenic patients.
    Lehmann CR; Ereshefsky L; Saklad SR; Mings TE
    Am J Psychiatry; 1981 Sep; 138(9):1212-4. PubMed ID: 7270726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical and therapeutic aspects of agitation].
    San L
    Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
    [No Abstract]   [Full Text] [Related]  

  • 48. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
    Schiele BC
    Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
    Simpson GM; Cuculic Z
    J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department.
    McDowell M; Nitti K; Kulstad E; Cirone M; Shah R; Rochford D; Walsh R; Hesse K
    Clin Neuropharmacol; 2019; 42(2):23-26. PubMed ID: 30747748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Statistical analysis of the activity of loxapine and thioridazine in a double-blind study].
    Rainaut J
    Encephale; 1975; 1(2):147-60. PubMed ID: 1100361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine.
    Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ
    J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the use of haloperidol a safe and effective method of tranquilization for patients with psychosis-induced aggression or agitation?
    Chandler A; Freeze-Ramsey R; Seupaul RA
    Ann Emerg Med; 2014 Jun; 63(6):757-8. PubMed ID: 24275570
    [No Abstract]   [Full Text] [Related]  

  • 55. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H; Gen K; Takahashi Y
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loxapine succinate: a comparative study with chlorpromazine.
    Dube KC; Kumar N
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):653-60. PubMed ID: 819223
    [No Abstract]   [Full Text] [Related]  

  • 57. Chlorpromazine for psychosis induced aggression or agitation.
    Ahmed U; Jones H; Adams CE
    Cochrane Database Syst Rev; 2010 Apr; (4):CD007445. PubMed ID: 20393959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute high-dose parenteral haloperidol treatment of psychosis.
    Lerner Y; Lwow E; Levitin A; Belmaker RH
    Am J Psychiatry; 1979 Aug; 136(8):1061-4. PubMed ID: 380367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
    Contreras SA; Maas JW; Seleshi E; Bowden CL
    Biol Psychiatry; 1988 Nov; 24(7):818-22. PubMed ID: 3067756
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.